Cybin
Why Robinhood?
You can watch Cybin and buy or sell other stocks, ETFs, and their options commission-free!About CYBN
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.
CYBN Key Statistics
Stock Snapshot
As of today, Cybin(CYBN) shares are valued at $5.74. The company's market cap stands at 286.39M, with a P/E ratio of -1.27.
On 2026-03-10, Cybin(CYBN) stock opened at —, reached a high of —, and a low of —.
The Cybin(CYBN)'s current trading volume is 0, compared to an average daily volume of 1.67M.
In the last year, Cybin(CYBN) shares hit a 52-week high of $9.83 and a 52-week low of $4.81.
In the last year, Cybin(CYBN) shares hit a 52-week high of $9.83 and a 52-week low of $4.81.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.